Long-term positive outcomes for artificial cervical discs were reported, but the market remains muted by insurance restrictions, and even more data may be needed for a breakthrough.
Multiple randomized studies reporting positive outcomes for artificial cervical discs were reported this month at the North American Spine Society meeting in Chicago.
But the market for the total cervical disc replacement procedure remains muted by insurance restrictions and even more data is likely necessary for a breakthrough, surgeons suggested at the meeting.
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.
